照護現場(POC)診斷的全球市場:2019年∼2023年

不斷成長的老年人口將在未來幾年推動照護現場(POC)診斷市場的成長。隨著免疫系統隨年齡的成長而惡化，老年人群中肺病、癌症和中風等疾病的患病率很高。由於其免疫力和新陳代謝低，老年人需要定期進行診斷檢測。這將導致對POC診斷設備的需求增加，因為這些設備有助於疾病診斷並幫助醫生選擇適當的治療選擇。因此，人口老齡化的增加將推動預測期間的照護現場(POC)診斷市場成長。Technavio的分析師預測，到2023年，照護現場(POC)診斷市場的年複合成長率將接近10％。

本報告提供全球照護現場(POC)診斷市場相關調查分析，市場規模與成長率，市場趨勢，市場的推動要素與課題，市場機會驗證，再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 報告的範圍

• 簡介1
• 簡介2
• 美金的貨幣換算比率

第3章 市場情形

• 市場生態系統
• 市場特徵
• 市場區隔分析

第4章 市場規模

• 市場定義
• 市場規模(2018年)
• 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

• 買主談判力
• 供應商談判力
• 新加入廠商的威脅
• 替代品的威脅
• 競爭對手的威脅
• 市場情況

第6章 市場區隔:各產品

• 市場區隔:各產品
• 各產品比較:市場規模及預測(2018年∼2023年)
• 血液診斷
• 感染疾病診斷
• 迅速心血管診斷
• 迅速凝固診斷
• 其他
• 市場機會:各產品

第7章 客戶形勢

第8章 市場區隔:各終端用戶

• 醫院、診療所
• 居家醫療
• 臨床診斷檢驗室

第9章 地區形勢pu

• 各地區市場區隔
• 各地區比較:市場規模及預測(2018年∼2023年)
• 北美
• 歐洲
• 亞洲
• 其他地區
• 主要國家
• 市場機會

第10章 決策架構

第11章 成長要素與課題

• 市場成長要素
• 市場課題

第12章 市場趨勢

第13章 業者情勢

• 概要
• 創造性破壞狀況

第14章 供應商分析

• 交易廠商
• 供應商分類
• 供應商的市場定位
• Abbott
• Danaher
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Sinocare Inc.

第15章 附錄

• 調查方法
• 簡稱的清單

第16章 關於TECHNAVIO

About this market

The growing geriatric population will drive the point of care (POC) diagnostics market growth in the forthcoming years. As the immune system deteriorates with age, the prevalence of diseases such as lung disease, cancer, and stroke are high among the aging population. Due to their low immunity and metabolism, the elderly requires diagnostic testing regularly. This will lead to an increase in the demand for POC diagnostic devices, as these devices assists in disease diagnosis and help the doctor choose the appropriate treatment option. As a result, the rising aging population will drive the point of care (POC) diagnostics market growth during the forecast period. Technavio's analysts have predicted that the point of care (POC) diagnostics market will register a CAGR of nearly 10% by 2023.

Market Overview

Increased focus on personalized medicine

One of the growth drivers of the global point of care (POC) diagnostics market is the increased focus on personalized medicine. The demand for personalized medicine is growing owing to the development of genome technology, whole genome technology, and companion diagnostics, which will increase the demand for diagnostic devices to diagnose diseases and perform treatment according to an individual's diagnostic response.

Stringent regulations

One of the challenges in the growth of the global point of care (POC) diagnostics market is the stringent regulations. Stringent government regulations in different countries affect the development and demand for devices such as POC diagnostics.

For the detailed list of factors that will drive and challenge the growth of the point of care (POC) diagnostics market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several hospitals and clinics are switching from conventional testing methods to POC testing due to their improved efficiency and faster turnaround times. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Hematology diagnostics - Market size and forecast 2018-2023
• Infectious disease diagnostics - Market size and forecast 2018-2023
• Rapid cardiovascular diagnostics - Market size and forecast 2018-2023
• Rapid coagulation diagnostics - Market size and forecast 2018-2023
• Others - Market size and forecast 2018-2023
• Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

• Hospitals and clinics
• Homecare settings
• Clinical diagnostic laboratories

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Danaher
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Sinocare Inc.

PART 15: APPENDIX

• Research methodology
• List of abbreviations

PART 16: EXPLORE TECHNAVIO

List of Exhibits

• Exhibit 01: Global healthcare market
• Exhibit 02: Segments of global healthcare market
• Exhibit 03: Market characteristics
• Exhibit 04: Market segments
• Exhibit 05: Market definition - Inclusions and exclusions checklist
• Exhibit 06: Market size 2018
• Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
• Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
• Exhibit 09: Five forces analysis 2018
• Exhibit 10: Five forces analysis 2023
• Exhibit 11: Bargaining power of buyers
• Exhibit 12: Bargaining power of suppliers
• Exhibit 13: Threat of new entrants
• Exhibit 14: Threat of substitutes
• Exhibit 15: Threat of rivalry
• Exhibit 16: Market condition - Five forces 2018
• Exhibit 17: Product - Market share 2018-2023 (%)
• Exhibit 18: Comparison by product
• Exhibit 19: Hematology diagnostics - Market size and forecast 2018-2023 ($ millions)
• Exhibit 20: Hematology diagnostics - Year-over-year growth 2019-2023 (%)
• Exhibit 21: Infectious disease diagnostics - Market size and forecast 2018-2023 ($ millions)
• Exhibit 22: Infectious disease diagnostics - Year-over-year growth 2019-2023 (%)
• Exhibit 23: Rapid cardiovascular diagnostics - Market size and forecast 2018-2023 ($ millions)
• Exhibit 24: Rapid cardiovascular diagnostics - Year-over-year growth 2019-2023 (%)
• Exhibit 25: Rapid coagulation diagnostics - Market size and forecast 2018-2023 ($ millions)
• Exhibit 26: Rapid coagulation diagnostics - Year-over-year growth 2019-2023 (%)
• Exhibit 27: Others - Market size and forecast 2018-2023 ($ millions)
• Exhibit 28: Others - Year-over-year growth 2019-2023 (%)
• Exhibit 29: Market opportunity by product
• Exhibit 30: Customer landscape
• Exhibit 31: Market segmentation by end-user 2018
• Exhibit 32: Market share by geography 2018-2023 (%)
• Exhibit 33: Geographic comparison
• Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
• Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
• Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
• Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
• Exhibit 38: Asia - Market size and forecast 2018-2023 ($ millions)
• Exhibit 39: Asia - Year-over-year growth 2019-2023 (%)
• Exhibit 40: ROW - Market size and forecast 2018-2023 ($ millions)
• Exhibit 41: ROW - Year-over-year growth 2019-2023 (%)
• Exhibit 42: Key leading countries
• Exhibit 43: Market opportunity
• Exhibit 44: Factors contributing to infections among aging population
• Exhibit 45: Impact of drivers and challenges
• Exhibit 46: Vendor landscape
• Exhibit 47: Landscape disruption
• Exhibit 48: Vendors covered
• Exhibit 49: Vendor classification
• Exhibit 50: Market positioning of vendors
• Exhibit 51: Abbott - Vendor overview
• Exhibit 52: Abbott - Business segments
• Exhibit 53: Abbott - Organizational developments
• Exhibit 54: Abbott - Geographic focus
• Exhibit 55: Abbott - Segment focus
• Exhibit 56: Abbott - Key offerings
• Exhibit 57: Danaher - Vendor overview
• Exhibit 58: Danaher - Business segments
• Exhibit 59: Danaher - Organizational developments
• Exhibit 60: Danaher - Geographic focus
• Exhibit 61: Danaher - Segment focus
• Exhibit 62: Danaher - Key offerings
• Exhibit 63: F. Hoffmann-La Roche Ltd - Vendor overview
• Exhibit 64: F. Hoffmann-La Roche Ltd - Business segments
• Exhibit 65: F. Hoffmann-La Roche Ltd - Organizational developments
• Exhibit 66: F. Hoffmann-La Roche Ltd - Geographic focus
• Exhibit 67: F. Hoffmann-La Roche Ltd - Segment focus
• Exhibit 68: F. Hoffmann-La Roche Ltd - Key offerings
• Exhibit 69: Siemens Healthineers AG - Vendor overview
• Exhibit 70: Siemens Healthineers AG - Business segments
• Exhibit 71: Siemens Healthineers AG - Organizational developments
• Exhibit 72: Siemens Healthineers AG - Geographic focus
• Exhibit 73: Siemens Healthineers AG - Segment focus
• Exhibit 74: Siemens Healthineers AG - Key offerings
• Exhibit 75: Sinocare Inc. - Vendor overview
• Exhibit 76: Sinocare Inc. - Business segments
• Exhibit 77: Sinocare Inc. - Organizational developments
• Exhibit 78: Sinocare Inc. - Key offerings
• Exhibit 79: Validation techniques employed for market sizing